1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. MINERALYS THERAPEUTICS INC
Mineralys Therapeutics Inc XNAS: MLYS

Mineralys Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

about

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administere...

Read More
33.37 0.24 (0.72%)
29.97% Fall from 52W High
1.4M
XNAS Volume

XNAS 09 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert
Durability score
Not Eligible
Valuation Score
Expensive Valuation
6.2 / 100
Momentum Score
Technically Neutral
54.3 / 100
Analyst Price Target
No estimates available

7

S

8

W

5

O

0

T

SWOT Analysis

Mineralys Therapeutics Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..